Advertisement

AAPS PharmSciTech

, 20:96 | Cite as

Enhanced Transdermal Drug Delivery by Sonophoresis and Simultaneous Application of Sonophoresis and Iontophoresis

  • Juhyun Park
  • Hyowon Lee
  • Guei-Sam Lim
  • Nayoung Kim
  • Dongwon Kim
  • Yeu-Chun KimEmail author
Research Article
  • 33 Downloads

Abstract

Transdermal drug delivery has advantages of topical drug administration compared to the other conventional administration methods. However, the skin penetration of drugs is limited by the barrier properties of stratum corneum. The combinational strategy has been investigated to improve the skin permeability of the drug. For this study, we devised an improved device that can perform not only the single application of sonophoresis or iontophoresis but also the simultaneous application. The enhancement effect of sonophoresis was evaluated for various cosmeceutical drugs using a Franz diffusion cell. The enhancement ratio of niacinamide and retinol with sonophoresis was increased to 402% and 292%, respectively. The relationship was found between the enhancement effect of sonophoresis and the physicochemical properties of drugs. In particular, the simultaneous treatment of sonophoresis and iontophoresis enhanced skin penetration of glutamic acid to 240% using the fabricated device. The simultaneous application showed significantly higher enhancement ratio than application of sonophoresis or iontophoresis alone. Moreover, the improved device achieved skin penetration enhancement of various cosmeceutical drugs with lower intensity and a short application time. This combined strategy of transdermal physical enhancement methods is advantageous in terms of decline in energy density, thereby reducing the skin irritation. The miniaturized device with sonophoresis and iontophoresis is a promising approach due to enhanced transdermal drug delivery and feasibility of self-administration in cosmetic and therapeutic fields.

KEY WORDS

sonophoresis ultrasound iontophoresis transdermal drug delivery skin penetration enhancer physical enhancer 

Notes

Funding Information

This work was supported financially by the Ministry of Science and ICT (Project No. NRF-2014M3A9E4064580), LG Electronics Inc., and the Animal and Plant Quarantine Agency, Gimcheon, Gyeongsangbuk-do, Republic of Korea (N04130146).

Supplementary material

12249_2019_1309_MOESM1_ESM.docx (1 mb)
ESM 1 (DOCX 1032 kb)

References

  1. 1.
    Lavon I, Kost J. Ultrasound and transdermal drug delivery. Drug Discov Today. 2004;9:670–6.CrossRefGoogle Scholar
  2. 2.
    Escobar-Chavez JJ, Merino-Sanjuán V, López-Cervantes M, Urban-Morlan Z, Pinon-Segundo E, Quintanar-Guerrero D, et al. The tape-stripping technique as a method for drug quantification in skin. J Pharm Pharm Sci. 2008;11:104–30.CrossRefGoogle Scholar
  3. 3.
    Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Investig Dermatol. 1991;96:495–9.CrossRefGoogle Scholar
  4. 4.
    Rejinold NS, Shin J-H, Seok HY, Kim Y-C. Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery. Expert Opin Drug Deliv. 2016;13:109–31.CrossRefGoogle Scholar
  5. 5.
    Amjadi M, Mostaghaci B, Sitti M. Recent advances in skin penetration enhancers for transdermal gene and drug delivery. Curr Gene Ther. 2017;17:139–46.CrossRefGoogle Scholar
  6. 6.
    Ain A, Karande P, Mitragotri S. Percutaneous penetration enhancers drug penetration into/through the skin, Chapter 8, High throughput screening of transdermal penetration enhancers: opportunities, methods, and applications. New York: Springer; 2017. p. 137–49.Google Scholar
  7. 7.
    Lee H, Park J, Kim Y-C. Enhanced transdermal delivery with less irritation by magainin pore-forming peptide with a N-lauroylsarcosine and sorbitan monolaurate mixture. Drug Deliv Transl Res. 2018;8:54–63.CrossRefGoogle Scholar
  8. 8.
    Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–24.CrossRefGoogle Scholar
  9. 9.
    Kim Y-C, Late S, Banga AK, Ludovice PJ, Prausnitz MR. Biochemical enhancement of transdermal delivery with magainin peptide: modification of electrostatic interactions by changing pH. Int J Pharm. 2008;362:20–8.CrossRefGoogle Scholar
  10. 10.
    Kang S-M, Song J-M, Kim Y-C. Microneedle and mucosal delivery of influenza vaccines. Expert Rev Vaccines. 2012;11:547–60.CrossRefGoogle Scholar
  11. 11.
    Bommannan D, Okuyama H, Stauffer P, Guy RH. Sonophoresis. I. The use of high-frequency ultrasound to enhance transdermal drug delivery. Pharm Res-Dordr. 1992;9:559–64.CrossRefGoogle Scholar
  12. 12.
    Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev. 2004;56:589–601.CrossRefGoogle Scholar
  13. 13.
    Ogura M, Paliwal S, Mitragotri S. Low-frequency sonophoresis: current status and future prospects. Adv Drug Deliv Rev. 2008;60:1218–23.CrossRefGoogle Scholar
  14. 14.
    Hikima T, Tojo K. Percutaneous penetration enhancers: physical methods in penetration enhancement, Chapter 11, Combined Use of Iontophoresis and Other Physical Methods. New York: Springer; 2017. p. 353–67.CrossRefGoogle Scholar
  15. 15.
    Tezel A, Sens A, Tuchscherer J, Mitragotri S. Frequency dependence of sonophoresis. Pharm Res-Dordr. 2001;18:1694–700.CrossRefGoogle Scholar
  16. 16.
    Azagury A, Khoury L, Enden G, Kost J. Ultrasound mediated transdermal drug delivery. Adv Drug Deliv Rev. 2014;72:127–43.CrossRefGoogle Scholar
  17. 17.
    Singh P, Maibach HI. Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug. 1994;11:161–213.Google Scholar
  18. 18.
    Anderson CR, Morris RL, Boeh SD, Panus PC, Sembrowich WL. Effects of iontophoresis current magnitude and duration on dexamethasone deposition and localized drug retention. Phys Ther. 2003;83:161–70.PubMedGoogle Scholar
  19. 19.
    Sieg A, Wascotte V. Diagnostic and therapeutic applications of iontophoresis. J Drug Target. 2009;17:690–700.CrossRefGoogle Scholar
  20. 20.
    Ita K. Transdermal iontophoretic drug delivery: advances and challenges. J Drug Target. 2016;24:386–91.CrossRefGoogle Scholar
  21. 21.
    Mitragotri. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov. 2005;4:255–60.CrossRefGoogle Scholar
  22. 22.
    Singhal M, Kalia YN. Skin permeation and disposition of therapeutic and cosmeceutical compounds, Iontophoresis and Electroporation. Tokyo: Springer Japan; 2017. p. 165–82.CrossRefGoogle Scholar
  23. 23.
    Shirouzu K, Nishiyama T, Hikima T, Tojo K. Synergistic effect of sonophoresis and iontophoresis in transdermal drug delivery. JCEJ. 2008;41:300–5.CrossRefGoogle Scholar
  24. 24.
    Le L, Kost J, Mitragotri S. Combined effect of low-frequency ultrasound and iontophoresis: applications for transdermal heparin delivery. Pharm Res-Dordr. 2000;17:1151–4.CrossRefGoogle Scholar
  25. 25.
    Hikima T, Ohsumi S, Shirouzu K, Tojo K. Mechanisms of synergistic skin penetration by sonophoresis and iontophoresis. Biol Pharm Bull. 2009;32:905–9.CrossRefGoogle Scholar
  26. 26.
    Fang J-Y, Hwang T-L, Huang Y-B, Tsai Y-H. Transdermal iontophoresis of sodium nonivamide acetate: V. Combined effect of physical enhancement methods. Int J Pharm. 2002;235:95–105.CrossRefGoogle Scholar
  27. 27.
    Mahl JA, Vogel BE, Court M, Kolopp M, Roman D, Nogués V. The minipig in dermatotoxicology: methods and challenges. Exp Toxicol Pathol. 2006;57:341–5.CrossRefGoogle Scholar
  28. 28.
    Yoshimatsu H, Ishii K, Konno Y, Satsukawa M, SJIjop Y. Prediction of human percutaneous absorption from in vitro and in vivo animal experiments. Int J Pharm. 2017;534:348–55.CrossRefGoogle Scholar
  29. 29.
    Morimoto Y, Mutoh M, Ueda H, Fang L, Hirayama K, Atobe M, et al. Elucidation of the transport pathway in hairless rat skin enhanced by low-frequency sonophoresis based on the solute–water transport relationship and confocal microscopy. J Control Release. 2005;103:587–97.CrossRefGoogle Scholar
  30. 30.
    Bolzinger M-A, Briançon S, Pelletier J, Chevalier Y. Penetration of drugs through skin, a complex rate-controlling membrane. Curr Opin Colloid Interface Sci. 2012;17:156–65.CrossRefGoogle Scholar
  31. 31.
    Terahara T, Mitragotri S, Kost J, Langer R. Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity. Int J Pharm. 2002;235:35–42.CrossRefGoogle Scholar
  32. 32.
    Watanabe S, Takagi S, Ga K, Yamamoto K, Aoyagi T. Enhanced transdermal drug penetration by the simultaneous application of iontophoresis and sonophoresis. J Drug Deliv. 2009;19:185–9.Google Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2019

Authors and Affiliations

  • Juhyun Park
    • 1
  • Hyowon Lee
    • 1
  • Guei-Sam Lim
    • 2
  • Nayoung Kim
    • 2
  • Dongwon Kim
    • 2
  • Yeu-Chun Kim
    • 1
    Email author
  1. 1.Department of Chemical and Biomolecular EngineeringKorea Advanced Institute of Science and TechnologyDaejeonRepublic of Korea
  2. 2.Medical Information Technology Team, Convergence CenterLG Electronics, Inc.SeoulRepublic of Korea

Personalised recommendations